-
-
Menin-MLL inhibitor 20,98%, 1mg
-
Diallyl tetrasulfide,≥90%, 5mg
-
Thalidomide-NH-C8-NH2 hydrochloride,≥95%(HPLC), 5mg
-
Thalidomide-NH-C8-NH2 hydrochloride,≥95%(HPLC), 25mg
-
Di-tert-butyl 1，4，5-oxadiazepane-4，5-dicarboxylate,97%, 100g
-
4-Benzyloxoy-3-methoxy
phenylboronic acid,97%, 250mg
-
4-Benzyloxoy-3-methoxy
phenylboronic acid,97%, 1g
-
2-((2S，3S)-3-(tert-Butyl)-4-(3，5-dicyclopentyl-2，6-dimethoxy
phenyl)-2，3-dihydrobenzo[d][1，3]oxaphosphol-2-yl)propan-2-ol,97%, 99%ee, 100mg
-
Di-tert-butyl 1，4，5-oxadiazepane-4，5-dicarboxylate,97%, 1g
-
Di-tert-butyl 1，4，5-oxadiazepane-4，5-dicarboxylate,97%, 5g
-
[S(R)]-N-[(S)-[2-(Diadamantanphosphino)
phenyl]
phenylmethyl]-N，2-dimethyl-2-propanesulfinamide,≥95%, 100mg
стр.: